OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
Cenduit LLC, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions as an interactive response technology (IRT) specialist at DIA next week, June 19-21, in Chicago. Same Osman, Cenduit's new CEO, will present at the show, and the company will launch its newest study build software, Quantum Interactive™.
Quantum Interactive is technology-based and increases IRT quality by creating a functioning prototype of an initial study build within minutes, according to the company. It is a user-friendly interface that guides the study building process for faster requirements discovery and is highly configurable, regardless of study design.
Read the full release here.
Related Content:
News